877-800-1700

medical research -

Report Delves Into Preventable Surgical Errors

By Los Angeles Personal Injury Lawyer on December 28, 2012

When you check into a hospital for a procedure, you count on the fact that certain no-brainer things will be handled appropriately so that the surgery itself will go off without a hitch.  The right body part will be operated on.  Equipment won’t be left behind inside your body when the procedure is finished.  You will receive the correct surgical procedure instead of being mixed up with the person down the hall.

These seem like things that should go without saying, but as new research suggests, mistakes of this nature occur far more regularly than patients might realize.  Researchers from the Johns Hopkins University School of Medicine have published a report in the Surgery online journal which suggests 4,082 mistakes similar to what’s described above occur on an annual basis.  These “never events” are things that are easily preventable but which nevertheless can severely compromise patient safety.

What’s also shocking is that, according to researchers, numerous such events never even get reported, and the patient often doesn’t receive an appropriate medical malpractice payout.  Incidents in which equipment gets left behind typically only are discovered once the patient suffers some type of complication, and if no such symptoms present themselves, things like surgical sponges may never be discovered.  It’s also highly likely that numerous patients might opt not to file a claim.

That’s why the researchers concluded that more than 4,000 never events occur every year even though only 9,744 such events were recorded in the 20 year time period between 1990 and 2010.  These are only those incidents which resulted in some sort of medical malpractice payment, and one study estimates that only about 12% of incidents result in the patient receiving such a financial reimbursement.

Leading the list of typical never events was an object being left behind, an occurrence which accounts for nearly 50% of all incidents.  Wrong procedures and wrong sites each made up about one quarter of the incidents, while wrong patient never events that resulted in a medical malpractice payment were relatively rare, only .3%.

It’s clear that hospitals must take steps to ensure that these events become increasingly uncommon.  We are seeing strides made in that department though.  Some hospitals have begun to institute procedures meant to cut down on error, such as placing scannable bar codes on every piece of equipment or running through a spot check before the procedure to ensure that every aspect of the operation goes smoothly and without an incident.

Yet some think the answer lies with monetary punishment.  A Harvard expert on patient safety believes that a $100,000 fine levied against all institutions that are the site of a never event might be the way to go.  If subsequent incidents result in even steeper fines, then hospitals might quickly see the benefit of enacting new safety procedures.

Stryker Wingspan Stent System Usage Instructions Tweaked by FDA

By Los Angeles Personal Injury Lawyer on August 10, 2012

The Food and Drug Administration has issued a warning to healthcare providers explaining to them that the instructions for use of the Stryker Wingspan Stent System have changed.  Used to widen the narrowed arteries of the brains of repeated stroke victims, these stents should, according to the FDA, only be used in a certain subset of patients who continue to have strokes and suffer from intracranial stenosis despite other medical treatment being attempted.

Click here for more information about this change.

Liberation Therapy MS Treatment Criticized by FDA

By Los Angeles Personal Injury Lawyer on May 14, 2012

A treatment that some claim can help combat multiple sclerosis is taking fire from the Food and Drug Administration because they say a correlation cannot be established that would prove the treatment’s efficacy.

Under scrutiny is a form of treatment known as liberation therapy.  This type of treatment involves using stents or balloon angioplasty devices to open up veins in the neck and chest that have otherwise been narrowed in persons suffering from what’s known as CCSI, or chronic cerebrospinal venous insufficiency.

How would this help multiple sclerosis?  Well, there are those out there who say that, because narrowed veins prevent the proper drainage of blood from the spinal cord or brain, the condition could actually contribute to or directly cause multiple sclerosis.

But the FDA disagrees, saying that there has been no link established between the two maladies. According to officials, there haven’t been any clinical trials that have been able to prove any kind of tie between MS and CCSI.  In fact, they go so far as to say that the liberation therapy treatment could potentially harm the patient.  There have been reports of stroke, abdominal bleeding, and even death among people who have undergone this liberation therapy.

The FDA is instead encouraging those affected with MS to speak with a physician to discuss alternative methods of treatment for their disease.

Helicopters Trauma Patient Rescue Rate Higher Than Ambulances

By Los Angeles Personal Injury Lawyer on April 17, 2012

If you’re involved in a life-threatening accident that requires immediate medical attention, then it’s imperative that you get to a trauma center as quickly as possible, and a new study suggests that you might be better off traveling by air than on the street.

The Journal of the American Medical Association has just published a study conducted by researchers at the University of Maryland School of Medicine which claims that accident victims with severe injuries are 1 to 2% more likely to survive if they’re transported to a trauma center via a helicopter rather than via an ambulance.

In compiling their findings, the researchers looked at 224,000 patients that had to receive treatments, 162,000 of which traveled in an ambulance.  By taking the findings just at face value, ambulances come out on top, with an 89% survival rate versus an 87% survival rate amongst helicopters.  But once researchers factored in age, distance away, likelihood of survival, and other factors, the numbers reversed themselves and helicopters came out on top.

Researchers are quick to point out that this shouldn’t be used as a blanket scenario, and that each case should be taken on its own merits depending on distance and time factors.

I found this study incredibly interesting as a car accident lawyer in San Diego.  I regularly read stories about persons being rescued and transported to a hospital to receive injury treatments, but I never thought to consider which method of transport was safer.  I hope as a San Diego personal injury lawyer that this research is the first step to saving the lives of accident victims all across the country.

Doctor Claims Riata Heart Implant Had Deadly Defect

By Los Angeles Personal Injury Lawyer on April 10, 2012

A battle is shaping up between the makers of a medical device and a doctor who is saying that a defect in the device directly contributed to the death of more than 20 people.

In the March issue of the Heart Rhythm Journal, a medical journal, a doctor has written a report about St. Jude Medical Inc.’s Riata heart implant device.  The findings published do not speak well of the product.  Specifically, the report discusses a defect in the insulation that led to certain high voltage components short circuiting and triggering a failure of the device itself.

In 2011, the Riata and Riata ST leads for implantable cardioverter defibrillators were recalled.  Now, though, the company that makes those devices, St. Jude’s, has asked that the new study be withdrawn from the print publication of the aforementioned magazine.  They are claiming that the defect has been resolved, saying that no wiring problems exist at the moment.  They point to their efforts to put additional coating on the wiring.  According to St. Jude’s, this technique has solved any problems that may have taken place.

As a San Jose personal injury lawyer, I’ve seen a number of medical devices get recalled because of a defect that compromises the stability of the item and the safety of the individual.  This is certainly one story I will be paying close attention to as a Ventura personal injury attorney.

FDA Partners with ISMP To Prevent Medication Errors

By Los Angeles Personal Injury Lawyer on April 2, 2012

The Food and Drug Administration is partnering with the Institute for Safe Medication Practices in an attempt to prevent costly and dangerous medication errors that could negatively impact consumers.

Medication errors can encompass any number of accidents, be it a mistake in labeling, a miscommunication, or a prescription mixup.  Typical cases can include a physician not having a proper patient history that includes all known allergens when prescribing meds, lookalike packaging that pharmacists have trouble correctly identifying, and poor methods of communication between a physician and a pharmacy that can contribute to a hazard.

One of the most notable functions that this new partnership can provide is the ability to disperse the appropriate information to relevant parties in the event of a medication error.  The ISMP, through its websites and newsletters, will be able to alert healthcare professionals should the FDA find an issue with a certain medicine or device.

By the same token, any issues that are brought to the ISMP’s attention through its various affiliates and Medication Errors Reporting Program can now be shared with the FDA through its Medwatch system. This system reports information on potential problems with medicine and medical devices, and ISMP can hopefully expand Medwatch’s breadth.

Such sharing can help the agencies spread awareness and determine the cause of a hazard to make sure it does not happen again.

As a Ventura personal injury lawyer, I’m glad to see steps taken to improve communication and safety.  Not everyone pays as close of attention to healthcare news as a Riverside personal injury attorney, and partnerships like this can help correct that.

FDA May Force Metal Hip Implants to Undergo More Testing

By Los Angeles Personal Injury Lawyer on March 29, 2012

The Food and Drug Administration might soon be imposing stiffer rules on a certain medical device.

It was announced today that the FDA would meet on June 27 and 28 to consider whether or not they should require metal on metal hip implants to face additional testing if such devices aim to gain approval by the organization.  This comes on the heels of numerous complaints regarding the devices.

Many people have endured the failure of such devices over the past few years, leaving the implants with a reputation of having a higher than acceptable rate of failure.  Devices made from other materials have not broken at the same rate.In fact, the National Joint Registry of England and Wales initiated a study which showed that 6% of recipients of a metal on metal implant device needed corrective surgery, compared with the more commonly accepted 2% that is normal with ceramics or plastics.

Last May, the FDA ruled that manufacturers needed to provide more data on these devices to demonstrate their safety.  Studies have also shown that metal devices can increase the level of metal ions in the blood, which could pose a danger.  The FDA wants more information about this scenario as well.

As a San Francisco personal injury lawyer, it grieves me to see an entire product line possibly do harm to the very people it was meant to help.  I hope the FDA makes the right decision in their June meeting, but whatever their choice, the impact will most certainly affect many people, including a Long Beach personal injury lawyer like me.

Bedford Labs Recalls Three Lots of Leukemia Fighting Drug

By Los Angeles Personal Injury Lawyer on March 8, 2012

A recall has been announced for an item that there’s already a shortage of thanks to a variety of other recalls.

Bedford Laboratories out of Ohio has issued a voluntary recall for three lots of cytarabine.  This is used in the treatment of leukemia, and is a particularly popular chemotherapy drug due to its irreplaceability in fighting the cancer.

Following an investigation at the plant where the drug was made, Bedford has said that they are concerned about the sterility of these particular lots, which have an expiration date between March 2014 and May 2014.  Production of the drug was previously halted due to a lack of required maintenance and testing of vital equipment.  It was resumed earlier this year.

Last month, the Food and Drug Administration asked for cytarabine, Doxil, and preservative-free methotrexate to be made available through additional sources because of rampant shortages that resulted from recalls and issues with manufacture.  Methotrexate is used to treat acute lymphoblastic leukemia in children, while Doxil is administered to women suffering from various cancers, including ovarian.

It saddens me as a personal injury lawyer in San Diego to think that certain life saving drugs might not be available, or that those drugs might have had a defect in the first place.  As a Ventura personal injury lawyer, I hope everyone who needs the drugs is able to receive them.

Children Mechanical Cardiac Assist Device Approved By FDA

By Los Angeles Personal Injury Lawyer on December 16, 2011

According to news sources, the Food and Drug Administration has recently approved a medical device to help children suffering from heart failure that will reportedly to stay alive while a heart transplant donor can be found.

The device us called EXCOR Pediatric System and was developed by Berlin Heart for the purpose of fitting the different sizes of children, from newborns to teenagers.

The average waiting time for a donor heart in the U.S is about 119 days due to the limited amount of pediatric sized donor hearts available usually available. The percentage of children with heart diseases who lose their lives while waiting for a heart transplant is reportedly about 23 percent.

The EXCOR device is intended to relieve some of the symptoms associated with heart disease until a heart transplant can be found, thereby increasing the chances of survival. It reportedly functions by pumping blood through multiple tubes to the heart chambers.

As a personal injury lawyer Los Angeles, I am glad to see advances being made in the medical field that will help those suffering from debilitating injuries and illnesses. The conclusions of this innovative endeavor seem to suggest benefits to patients who suffer from heart disease. As a Los Angeles personal injury attorney, I hope that readers will find this information useful.

Los Angeles Personal Injury Trial Lawyer Disclaimer: The personal injury, wrongful death, catastrophic injury, or other legal information presented at this site should not be considered formal legal advice, nor the formation of a lawyer or attorney client relationship. Prior results do not guarantee or predict a similar outcome with respect to any future matter. Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.

Copyright © 2013 Panish Shea & Boyle - Los Angeles Personal Injury Lawyers - California Product Liability Trial Attorneys - Top Plaintiffs Lawyers Los Angeles California. All rights reserved.

Lawyer Website Design and Search Engine Optimization by Legal Marketing Advantage

11111 Santa Monica Blvd.
Suite 700
Los Angeles CA 90025
F: 310-477-1699
Toll Free: 877-800-1700